Skip to content

Medication reviews in geriatric patients in long-term care facilities

Medication reviews in geriatric patients in long-term care facilities

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
DRKS
Registry ID
DRKS00026120
Enrollment
200
Registered
2021-09-07
Start date
2015-03-25
Completion date
Unknown
Last updated
2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Drug related problems in the prescription and use of medication in geriatric patients.

Interventions

Group 1: Patients in the intervention group receive a one-time medication review, which is performed by a pharmacist and subsequently coordinated with the healthcare professionals involved. Drug relat

Sponsors

Klinische Pharmazie Institut für Pharmazie Universität Leipzig
Lead Sponsor

Eligibility

Sex/Gender
All
Age
65 Years to No maximum

Inclusion criteria

Inclusion criteria: Age = 65, long-term/chronic medications = 3, and multimorbidity with = 3 comorbidities, written consent from the resident, or in the case of cognitive impairment, from the legally responsible party.

Exclusion criteria

Exclusion criteria: No present consent to study participation; life expectancy of less than six months.

Design outcomes

Primary

MeasureTime frame
Medication changes (based on changes in resident's medication records).

Secondary

MeasureTime frame
Falls, hospital admissions, death.

Countries

Germany

Contacts

Public ContactThilo Bertsche

Klinische Pharmazie Institut für Pharmazie Universität Leipzig

Thilo.Bertsche@uni-leipzig.de03419711800

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 18, 2026